trial

To Rescue Cognition With Valaciclovir

NCTId NCT01364792
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 24 (actual)
Sponsored by University Medical Center Groningen
Primary completion 2015-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
24 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2011-04
Primary completion
2015-08
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Valaciclovir

Sponsors

University Medical Center GroningenLead Sponsor
Stanley Medical Research InstituteCollaborator

Investigators

1
Robert A Schoevers, MD, Prof.Study Chair

Sites

1 total
Groningen, Netherlands

Linked catalysts

1
To Rescue Cognition With Valaciclovir — primary completion2015-08

Facts & assertions

4 sourced
Enrollment
24
Phase
PHASE2
Primary Completion Date
2015-08
Status
COMPLETED
relationships
The graph out of here
drug
Valaciclovir
drug
lead_sponsor
University Medical Center Groningen
company
collaborator
Stanley Medical Research Institute
company
indication
Psychosis
indication
Neuroinflammatory Diseases
indication
Schizophrenia
indication
investigator
Robert A Schoevers, MD, Prof.
person